|
Eisai currently works across Europe in the areas of Alzheimer’s disease, gastro-intestinal disorders, epilepsy, cervical dystonia, severe chronic pain and oncology. |
Halaven®
Eribulin mesylate
The Summary of Product Characteristics and the Patient Information Leaflet (PIL), can be found at www.emc.medicines.org.uk.
Click here and the halaven.eu website will open in a separate window www.halaven.eu
